Drug Type Small molecule drug |
Synonyms Diphenadione + [1] |
Target |
Mechanism TOP2A inhibitors(Topoisomerase (DNA) II alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H16O3 |
InChIKeyJYGLAHSAISAEAL-UHFFFAOYSA-N |
CAS Registry82-66-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | US | - | |
Multiple Myeloma | Preclinical | US | - |